Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Liver Transplantation

Free Subscription Articles published in Transpl Int Retrieve available abstracts of 145 articles: HTML format

Single Articles

January 2023
1. KO D, Ridner SH, Gifford KA
   Subjective Cognition is Related to Patient-Reported Symptom Distress and Work Productivity Among Liver Transplant Recipients.
   Transpl Int. 2023;36:10863.
   PubMed     Abstract available
   
   
   
2. STRINGA P, Vecchio Dezillio LE, Talayero P, Serradilla J, et al
   Experimental Assessment of Intestinal Damage in Controlled Donation After Circulatory Death for Visceral Transplantation.
   Transpl Int. 2023;36:10803.
   PubMed     Abstract available
   
   
   
3. ZENG J, Li Q, Wu Q, Li L, et al
   A Novel Online Calculator Predicting Acute Kidney Injury After Liver Transplantation: A Retrospective Study.
   Transpl Int. 2023;36:10887.
   PubMed     Abstract available
   
   
   
4. CORTESI PA, Vigano R, Conti S, Lenci I, et al
   Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation.
   Transpl Int. 2023;36:10954.
   PubMed     Abstract available
   
   
   
5. KRENDL FJ, Fodor M, Messner F, Balog A, et al
   Liver Transplantation in Recipients With a Positive Crossmatch: A Retrospective Single-Center Match-Pair Analysis.
   Transpl Int. 2023;36:11062.
   PubMed     Abstract available
   
   
   
6. MUHAMMAD I, Rehman FUL, Wang F, Xiong X, et al
   Application Effectiveness of Segment IV Portal Vein Reconstruction for Early Postoperative Liver Function Recovery in Split Liver Transplantation.
   Transpl Int. 2023;36:10808.
   PubMed     Abstract available
   
   
   
7. ANDACOGLU O, Izzy M, Adelmann D, Aguilera V, et al
   Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.
   Transpl Int. 2023;36:11240.
   PubMed     Abstract available
   
   
   
8. SEBAGH M, Yilmaz F, Kounis I, Saliba F, et al
   Evidence for Alloimmune Sinusoidal Injury in De Novo Nodular Regenerative Hyperplasia After Liver Transplantation.
   Transpl Int. 2023;36:11306.
   PubMed     Abstract available
   
   
   
9. GROSSI AA, Puoti F, Masiero L, Troni A, et al
   Inequities in Organ Donation and Transplantation Among Immigrant Populations in Italy: A Narrative Review of Evidence, Gaps in Research and Potential Areas for Intervention.
   Transpl Int. 2023;36:11216.
   PubMed     Abstract available
   
   
   
10. FALLANI G, Stocco A, Siniscalchi A, Antonini MV, et al
    Beyond the Concepts of Elder and Marginal in DCD Liver Transplantation: A Prospective Observational Matched-Cohort Study in the Italian Clinical Setting.
    Transpl Int. 2023;36:11697.
    PubMed     Abstract available
    
    
    
11. QAZI ARISAR FA, Salinas-Miranda E, Ale Ali H, Lajkosz K, et al
    Development of a Radiomics-Based Model to Predict Graft Fibrosis in Liver Transplant Recipients: A Pilot Study.
    Transpl Int. 2023;36:11149.
    PubMed     Abstract available
    
    
    
12. BERENGUER M, de Martin E, Hessheimer AJ, Levitsky J, et al
    European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation.
    Transpl Int. 2023;36:11358.
    PubMed     Abstract available
    
    
    
13. OLANDER AE, Helenius-Hietala J, Nordin A, Savikko J, et al
    Association Between Pre-Transplant Oral Health and Post-Liver Transplant Complications.
    Transpl Int. 2023;36:11534.
    PubMed     Abstract available
    
    
    January 2022
14. LEE CY, Wu MY, Chan HC, Chen TT, et al
    The Influence of Diabetes Mellitus on the Risks of End-Stage Kidney Disease and Mortality After Liver Transplantation.
    Transpl Int. 2022;36:10023.
    PubMed     Abstract available
    
    
    
15. SANADA Y, Sakuma Y, Onishi Y, Okada N, et al
    Hepatolithiasis After Living Donor Liver Transplantation in Pediatric Patients: Mechanism, Diagnosis, Treatment, and Prognosis.
    Transpl Int. 2022;36:10220.
    PubMed     Abstract available
    
    
    
16. DALZELL C, Vargas PA, Soltys K, Dipaola F, et al
    Living Donor Liver Transplantation vs. Split Liver Transplantation Using Left Lateral Segment Grafts in Pediatric Recipients: An Analysis of the UNOS Database.
    Transpl Int. 2022;36:10437.
    PubMed     Abstract available
    
    
    
17. KITANO Y, Pietrasz D, Fernandez-Sevilla E, Golse N, et al
    Subjective Difficulty Scale in Liver Transplantation: A Prospective Observational Study.
    Transpl Int. 2022;35:10308.
    PubMed     Abstract available
    
    
    
18. SAKAI A, Morishita T, Matsunami H
    Antibody Response After a Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Liver Transplant Recipients.
    Transpl Int. 2022;35:10321.
    PubMed    
    
    
    
19. FRIEND P, Pollok JM
    Hypothermic Machine Perfusion in Liver Transplantation-A Randomised Trial and Beyond.
    Transpl Int. 2022;35:10257.
    PubMed    
    
    
    
20. HERRERO A, Boivineau L, Cassese G, Assenat E, et al
    Progression of AFP SCORE is a Preoperative Predictive Factor of Microvascular Invasion in Selected Patients Meeting Liver Transplantation Criteria for Hepatocellular Carcinoma.
    Transpl Int. 2022;35:10412.
    PubMed     Abstract available
    
    
    
21. BECKMANN S, Kunzler-Heule P, Kabut K, Mauthner O, et al
    The Main Thing is to be Alive-Exploring Patients' Experiences With Weight Gain After Liver Transplantation: A Qualitative Study.
    Transpl Int. 2022;35:10256.
    PubMed     Abstract available
    
    
    
22. NEDKOVA-HRISTOVA V, Baliellas C, Gonzalez-Costello J, Llado L, et al
    Treatment With Diflunisal in Domino Liver Transplant Recipients With Acquired Amyloid Neuropathy.
    Transpl Int. 2022;35:10454.
    PubMed     Abstract available
    
    
    
23. SEEHOFER D, Petrowsky H, Schneeberger S, Vibert E, et al
    Patient Selection for Downstaging of Hepatocellular Carcinoma Prior to Liver Transplantation-Adjusting the Odds?
    Transpl Int. 2022;35:10333.
    PubMed     Abstract available
    
    
    
24. KIM MS, Hong SK, Woo HY, Cho JH, et al
    Optimal Intervention for Initial Treatment of Anastomotic Biliary Complications After Right Lobe Living Donor Liver Transplantation.
    Transpl Int. 2022;35:10044.
    PubMed     Abstract available
    
    
    
25. CUK N, Melamed KH, Vangala S, Salah R, et al
    Postoperative Trapped Lung After Orthotopic Liver Transplantation is a Predictor of Increased Mortality.
    Transpl Int. 2022;35:10387.
    PubMed     Abstract available
    
    
    
26. YAMAGUCHI N, Matsuyama R, Kikuchi Y, Sato S, et al
    Role of the Intramural Vascular Network of the Extrahepatic Bile Duct for the Blood Circulation in the Recipient Extrahepatic Bile Duct Used for Duct-to-Duct-Biliary-Anastomosis in Living Donor Liver Transplantation.
    Transpl Int. 2022;35:10276.
    PubMed     Abstract available
    
    
    
27. SCHULZ MS, Gu W, Schnitzbauer AA, Trebicka J, et al
    Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure.
    Transpl Int. 2022;35:10108.
    PubMed     Abstract available
    
    
    
28. SERRANO MT, Sabroso S, Esteban LM, Berenguer M, et al
    Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort.
    Transpl Int. 2022;35:10263.
    PubMed     Abstract available
    
    
    
29. DE SIMONE P, Ghinolfi D
    Hospital-Based Health Technology Assessment of Machine Perfusion Systems for Human Liver Transplantation.
    Transpl Int. 2022;35:10405.
    PubMed     Abstract available
    
    
    
30. HUNT F, Johnston CJC, Coutts L, Sherif AE, et al
    From Haphazard to a Sustainable Normothermic Regional Perfusion Service: A Blueprint for the Introduction of Novel Perfusion Technologies.
    Transpl Int. 2022;35:10493.
    PubMed     Abstract available
    
    
    
31. GEORGES P, Clerc C, Turco C, Di Martino V, et al
    Post-Transplantation Cytomegalovirus Infection Interplays With the Development of Anastomotic Biliary Strictures After Liver Transplantation.
    Transpl Int. 2022;35:10292.
    PubMed     Abstract available
    
    
    
32. HANN A, Nutu A, Clarke G, Patel I, et al
    Normothermic Machine Perfusion-Improving the Supply of Transplantable Livers for High-Risk Recipients.
    Transpl Int. 2022;35:10460.
    PubMed     Abstract available
    
    
    
33. DINGFELDER J, Rauter L, Berlakovich GA, Kollmann D, et al
    Biliary Viability Assessment and Treatment Options of Biliary Injury During Normothermic Liver Perfusion-A Systematic Review.
    Transpl Int. 2022;35:10398.
    PubMed     Abstract available
    
    
    
34. SMEDMAN TM, Guren TK, Tveit KM, Thomsen M, et al
    Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy.
    Transpl Int. 2022;35:10404.
    PubMed     Abstract available
    
    
    
35. AGUILERA I, Sousa JM
    Comments on: Differential IgG4-Producing Plasma Cell Infiltration in Non- and Post-Transplant Plasma Cell Hepatitis.
    Transpl Int. 2022;35:10590.
    PubMed    
    
    
    
36. AGUILERA V, Andacoglu O, Francoz C, Berlakovich G, et al
    Gender and Racial Disparity Among Liver Transplantation Professionals: Report of a Global Survey.
    Transpl Int. 2022;35:10506.
    PubMed     Abstract available
    
    
    
37. SHIMADA S, Shamaa T, Ivanics T, Kitajima T, et al
    Liver Transplant Recipient Characteristics Associated With Worse Post-Transplant Outcomes in Using Elderly Donors.
    Transpl Int. 2022;35:10489.
    PubMed     Abstract available
    
    
    
38. ZHOU GP, Wei L, Zhu ZJ
    Adopting Individualized Strategies to Prevent Large-For-Size Syndrome in Adult Liver Transplant Recipients: The Graft Morphology Should Also Be Taken Into Account.
    Transpl Int. 2022;35:10683.
    PubMed    
    
    
    
39. HE D, Pu X, Jiang L
    How to Choose the Optimal Surgical Strategy to Predict and Prevent LFSS Following Liver Transplantation?
    Transpl Int. 2022;35:10805.
    PubMed    
    
    
    
40. EEROLA V, Helantera I, Aberg F, Lempinen M, et al
    Timing of Organ Procurement From Brain-Dead Donors Associates With Short- and Long-Term Outcomes After Liver Transplantation.
    Transpl Int. 2022;35:10364.
    PubMed     Abstract available
    
    
    
41. JETTEN WD, Hogenbirk RNM, Van Meeteren NLU, Cuperus FJC, et al
    Physical Effects, Safety and Feasibility of Prehabilitation in Patients Awaiting Orthotopic Liver Transplantation, a Systematic Review.
    Transpl Int. 2022;35:10330.
    PubMed     Abstract available
    
    
    
42. YAO S, Yagi S, Ogawa E, Hirata M, et al
    Dysbiosis and Depletion of Fecal Organic Acids Correlate With the Severity of Rejection After Rat Liver Transplantation.
    Transpl Int. 2022;35:10728.
    PubMed     Abstract available
    
    
    
43. CHOTALIA M, Topiwala U, Iqbal A, Parekh D, et al
    Incidence of Gastrointestinal Bleeding After Transesophageal Echocardiography Use in Orthotopic Liver Transplantation.
    Transpl Int. 2022;35:10753.
    PubMed     Abstract available
    
    
    
44. BEETZ O, Cammann S, Weigle CA, Sieg L, et al
    Interleukin-18 and High-Mobility-Group-Protein B1 are Early and Sensitive Indicators for Cell Damage During Normothermic Machine Perfusion after Prolonged Cold Ischemic Storage of Porcine Liver Grafts.
    Transpl Int. 2022;35:10712.
    PubMed     Abstract available
    
    
    
45. LAI Q, Lerut J
    A Western World Perspective of Survival Benefit of Living Donor Liver Transplantation: A Commentary to the Article by Jackson et al. Published in JAMA Surgery.
    Transpl Int. 2022;35:10931.
    PubMed    
    
    
    
46. SAFDAR NZ, Hakeem AR, Faulkes R, James F, et al
    Outcomes After Liver Transplantation With Incidental Cholangiocarcinoma.
    Transpl Int. 2022;35:10802.
    PubMed     Abstract available
    
    
    
47. MINOUX K, Lassailly G, Ningarhari M, Lubret H, et al
    Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation.
    Transpl Int. 2022;35:10569.
    PubMed     Abstract available
    
    
    
48. MEIER RPH, Kelly Y, Braun H, Maluf D, et al
    Comparison of Biliary Complications Rates After Brain Death, Donation After Circulatory Death, and Living-Donor Liver Transplantation: A Single-Center Cohort Study.
    Transpl Int. 2022;35:10855.
    PubMed     Abstract available
    
    
    
49. TOMIYAMA T, Harada N, Toshima T, Nakayama Y, et al
    Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study.
    Transpl Int. 2022;35:10723.
    PubMed     Abstract available
    
    
    
50. FERNANDEZ-CARRILLO C, Li Y, Ventura-Cots M, Argemi J, et al
    Poor Outcomes of Patients With NAFLD and Moderate Renal Dysfunction or Short-Term Dialysis Receiving a Liver Transplant Alone.
    Transpl Int. 2022;35:10443.
    PubMed     Abstract available
    
    
    
51. TOTI L, Manzia TM, Blasi F, Lenci I, et al
    Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study.
    Transpl Int. 2022;35:10384.
    PubMed     Abstract available
    
    
    December 2021
52. AVOLIO AW, Contegiacomo A, Spoletini G, Moschetta G, et al
    Toward a novel evidence-based definition of early allograft failure in the perspective of liver retransplant.
    Transpl Int. 2021;34:2905-2907.
    PubMed    
    
    
    
53. KARATOPRAK S, Kutlu R, Karatoprak NB, Dag N, et al
    Percutaneous radiological biliary interventions after failed endoscopic treatment in living liver donors: experience of a high-volume transplantation center.
    Transpl Int. 2021;34:2846-2855.
    PubMed     Abstract available
    
    
    November 2021
54. ORCI LA, Combescure C, Fink M, Oldani G, et al
    Predicting recurrence of hepatocellular carcinoma after liver transplantation using a novel model that incorporates tumor and donor-related factors.
    Transpl Int. 2021 Nov 16. doi: 10.1111/tri.14161.
    PubMed     Abstract available
    
    
    
55. ABERG F, Abrahamsson J, Schult A, Bennet W, et al
    The RETREAT score provides valid predictions regarding hepatocellular carcinoma recurrence after liver transplantation.
    Transpl Int. 2021 Nov 14. doi: 10.1111/tri.14159.
    PubMed     Abstract available
    
    
    
56. SNEIDERS D, van Dijk ARM, Polak WG, Mirza DF, et al
    Full-left-full-right split liver transplantation for adult recipients: A systematic review and meta-analysis.
    Transpl Int. 2021 Nov 13. doi: 10.1111/tri.14160.
    PubMed     Abstract available
    
    
    
57. TEO VXY, Heng RRY, Tay PWL, Ng CH, et al
    A Meta-Analysis on the Prevalence of Chronic Kidney Disease in Liver Transplant Candidates and its Associated Risk Factors and Outcomes.
    Transpl Int. 2021 Nov 13. doi: 10.1111/tri.14158.
    PubMed     Abstract available
    
    
    
58. LIN J, Ko CJ, Lin KH, Hung YJ, et al
    The Glissonian Stitch Traction for Biliary Duct Manipulation in Living Donor Liver Transplantation.
    Transpl Int. 2021 Nov 8. doi: 10.1111/tri.14155.
    PubMed     Abstract available
    
    
    
59. BHANJI RA, Chow J, Ma M, Pannu N, et al
    Post liver transplantation chronic kidney disease is associated with increased cardiovascular disease risk and poor survival.
    Transpl Int. 2021 Nov 5. doi: 10.1111/tri.14154.
    PubMed     Abstract available
    
    
    
60. NUTU OA, Sneiders D, Mirza D, Isaac J, et al
    Safety of intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma, a propensity-score matched survival analysis.
    Transpl Int. 2021 Nov 1. doi: 10.1111/tri.14150.
    PubMed     Abstract available
    
    
    
61. DUELAND S, Smedman TM, Rosok B, Grut H, et al
    Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases.
    Transpl Int. 2021;34:2205-2213.
    PubMed     Abstract available
    
    
    
62. YILMAZ S, Akbulut S, Usta S, Ozsay O, et al
    Diagnostic and therapeutic management algorithm for biliary complications in living liver donors.
    Transpl Int. 2021;34:2226-2237.
    PubMed     Abstract available
    
    
    
63. FANG W, Noda M, Gotoh K, Morooka Y, et al
    Fatty liver disease in living liver donors: a single-institute experience of 220 donors.
    Transpl Int. 2021;34:2238-2246.
    PubMed     Abstract available
    
    
    
64. WU G, Liu Y, Rui C, Zhan S, et al
    An oxygenated perfluorocarbon emulsion improves liver graft preservation evaluated in DCD livers of male sprague dawley rats.
    Transpl Int. 2021;34:2087-2097.
    PubMed     Abstract available
    
    
    
65. CAPELLI R, Kitano Y, Linhares M, Da Silva D, et al
    The prognostic significance of serum aspartate transaminase and gamma-glutamyl transferase in liver deceased donors.
    Transpl Int. 2021;34:2247-2256.
    PubMed     Abstract available
    
    
    October 2021
66. LIM SY, Wang R, Tan DJH, Ng CH, et al
    A Meta-Analysis of the Cumulative Incidence, Risk Factors, and Clinical Outcomes associated with Chronic Kidney Disease after Liver Transplantation.
    Transpl Int. 2021 Oct 29. doi: 10.1111/tri.14149.
    PubMed     Abstract available
    
    
    September 2021
67. YUAN Q, Haque O, Yeh H, Markmann JF, et al
    The impact of race and comorbid conditions on adult liver transplant outcomes in obese recipients.
    Transpl Int. 2021 Sep 27. doi: 10.1111/tri.14125.
    PubMed     Abstract available
    
    
    
68. IVANICS T, Leonard-Murali S, Mouzaihem H, Moonka D, et al
    Extreme Hyponatremia as a Risk Factor for Early Mortality after Liver Transplantation in the MELD-Sodium Era.
    Transpl Int. 2021 Sep 27. doi: 10.1111/tri.14123.
    PubMed     Abstract available
    
    
    
69. ANDRES A, Sapisochin G, Nadalin S, Adam R, et al
    Liver transplantation for colorectal liver metastasis: aiming for a cure or a palliation?
    Transpl Int. 2021 Sep 7. doi: 10.1111/tri.14032.
    PubMed     Abstract available
    
    
    
70. BRIGGS G, Wallace D, Flasche S, Walker K, et al
    Inferior outcomes in young adults undergoing liver transplantation - A UK & ireland cohort study.
    Transpl Int. 2021 Sep 6. doi: 10.1111/tri.14033.
    PubMed     Abstract available
    
    
    
71. CENTONZE L, Di Sandro S, Lauterio A, De Carlis R, et al
    A retrospective single-centre analysis of the oncological impact of LI-RADS classification applied to Metroticket 2.0 calculator in liver transplantation: every nodule matters.
    Transpl Int. 2021;34:1712-1721.
    PubMed     Abstract available
    
    
    
72. LANARI J, Hagness M, Sartori A, Rosso E, et al
    Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score.
    Transpl Int. 2021;34:1722-1732.
    PubMed     Abstract available
    
    
    
73. DE STEFANO N, Navarro-Tableros V, Roggio D, Calleri A, et al
    Human liver stem cell-derived extracellular vesicles reduce injury in a model of normothermic machine perfusion of rat livers previously exposed to a prolonged warm ischemia.
    Transpl Int. 2021;34:1607-1617.
    PubMed     Abstract available
    
    
    August 2021
74. BEKKI Y, Von Ahrens D
    The long-term outcomes in liver transplantation using donation after circulatory death grafts.
    Transpl Int. 2021 Aug 21. doi: 10.1111/tri.14023.
    PubMed     Abstract available
    
    
    
75. TSIEN C, Selzner N
    PSC Recurrence Post Liver Transplantation: Re-Transplantation justified or not?
    Transpl Int. 2021 Aug 19. doi: 10.1111/tri.14014.
    PubMed     Abstract available
    
    
    
76. GROTTENTHALER JM, Konzelmann A, Stiegler A, Hinterleitner C, et al
    Significance and clinical impact of routinely tested urinary ethyl glucuronide after liver transplantation - development of a risk score.
    Transpl Int. 2021 Aug 6. doi: 10.1111/tri.14007.
    PubMed     Abstract available
    
    
    
77. CABALLERO-MARCOS A, Romero-Cristobal M, Puerto M, Fernandez-Yunquera A, et al
    HCV Eradication in Recurrent Hepatitis C after Liver Transplantation Normalizes Enhanced Endothelial Activation.
    Transpl Int. 2021 Aug 3. doi: 10.1111/tri.14000.
    PubMed     Abstract available
    
    
    July 2021
78. PERETZ D, On NH, Miller D, Kim R, et al
    Pharmacokinetics of a Once Daily Tacrolimus Formulation in First Nations and Caucasian Liver Transplant Recipients.
    Transpl Int. 2021 Jul 28. doi: 10.1111/tri.13997.
    PubMed     Abstract available
    
    
    
79. NG CH, Lim WH, Lim XC, Xiao J, et al
    A Meta-Analysis on the Incidence of Donor Related Depression after Liver Transplant.
    Transpl Int. 2021 Jul 17. doi: 10.1111/tri.13975.
    PubMed     Abstract available
    
    
    
80. MCDONALD MF, Barrett SC, Malik TH, Anand A, et al
    Elevated Serum Sodium in Recipients of Liver Transplantation Has a Substantial Impact on Outcomes.
    Transpl Int. 2021 Jul 4. doi: 10.1111/tri.13968.
    PubMed     Abstract available
    
    
    
81. GROTTENTHALER JM, Fuger JK, Mahling M, Konigsrainer A, et al
    Dynamics of glucose metabolism after liver transplantation: Prediabetes as a window of opportunity for patient survival and long-term kidney function.
    Transpl Int. 2021 Jul 2. doi: 10.1111/tri.13967.
    PubMed     Abstract available
    
    
    June 2021
82. AL-KURD A, Kitajima T, Delvecchio K, Shamaa MT, et al
    Short recipient warm ischemia time improves outcomes in deceased donor liver transplantation.
    Transpl Int. 2021 Jun 25. doi: 10.1111/tri.13962.
    PubMed     Abstract available
    
    
    
83. EMAMAULLEE J, Conrad C, Kim M, Goldbeck C, et al
    Assessment of the Global Practice of Living Donor Liver Transplantation.
    Transpl Int. 2021 Jun 24. doi: 10.1111/tri.13960.
    PubMed     Abstract available
    
    
    
84. AMYGDALOS I, Bednarsch J, Meister FA, Erren D, et al
    Clinical value and limitations of the preoperative C-reactive-protein-to-albumin ratio in predicting postoperative morbidity and mortality after deceased-donor liver transplantation: a retrospective single-centre study.
    Transpl Int. 2021 Jun 22. doi: 10.1111/tri.13957.
    PubMed     Abstract available
    
    
    
85. LAUTERIO A, De Carlis R, Valsecchi M, Vella I, et al
    Liver transplantation during the COVID-19 pandemic: a 2020 year-end report from Lombardy, northern Italy.
    Transpl Int. 2021 Jun 18. doi: 10.1111/tri.13953.
    PubMed     Abstract available
    
    
    
86. CUSUMANO C, De Carlis L, Centonze L, Lesourd R, et al
    Advanced donor age does not increase risk of hepatocellular carcinoma recurrence after liver transplantation: a retrospective two-center analysis using competing risk analysis.
    Transpl Int. 2021 Jun 18. doi: 10.1111/tri.13950.
    PubMed     Abstract available
    
    
    
87. HANN A, Sneiders D, Hartog H, Perera MTPR, et al
    Commentary on: Short recipient warm ischemia time improves outcomes in deceased donor liver transplantation.
    Transpl Int. 2021 Jun 18. doi: 10.1111/tri.13949.
    PubMed     Abstract available
    
    
    
88. CAMPOS-VARELA I, Len O, Villagrasa A, Marquez-Algaba E, et al
    Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort.
    Transpl Int. 2021 Jun 14. doi: 10.1111/tri.13946.
    PubMed     Abstract available
    
    
    May 2021
89. VISSEREN T, Erler NS, Polak WG, Adam R, et al
    Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond.
    Transpl Int. 2021 May 24. doi: 10.1111/tri.13925.
    PubMed     Abstract available
    
    
    
90. UCHIDA H, Sakamoto S, Kasahara M, Ueno Y, et al
    An analysis of the outcomes in living donor liver transplantation for pediatric malignant hepatic tumors using nationwide survey data in Japan.
    Transpl Int. 2021 May 22. doi: 10.1111/tri.13924.
    PubMed     Abstract available
    
    
    
91. D'AMICO G, Matsushima H, Diago Uso T, Armanyous SR, et al
    Long Term Outcomes and Complications of Reno-portal Anastomosis in Liver Transplantation: Results from a Propensity Score-Based Outcome Analysis.
    Transpl Int. 2021 May 18. doi: 10.1111/tri.13920.
    PubMed     Abstract available
    
    
    
92. PASSAMONTI SM, Cannavo A, Panigada M, Trunzo V, et al
    Donation after circulatory death (DCD) and liver transplantation: a cohort study.
    Transpl Int. 2021 May 18. doi: 10.1111/tri.13919.
    PubMed     Abstract available
    
    
    
93. IVANICS T, Shwaartz C, Claasen MPAW, Patel MS, et al
    Trends in Indications and Outcomes of Liver Transplantation in Canada: A Multi Centre Retrospective Study.
    Transpl Int. 2021 May 11. doi: 10.1111/tri.13903.
    PubMed     Abstract available
    
    
    
94. NITTA H, Younes A, El-Domiaty N, Karam V, et al
    High Trough Levels of Everolimus Combined to Sorafenib Improve Patients Survival After Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients.
    Transpl Int. 2021 May 1. doi: 10.1111/tri.13897.
    PubMed     Abstract available
    
    
    
95. LAROCHE S, Maulat C, Kitano Y, Golse N, et al
    Initial piggyback technique facilitates late liver retransplantation - a retrospective monocentric study.
    Transpl Int. 2021;34:835-843.
    PubMed     Abstract available
    
    
    April 2021
96. HO OTW, Ng WCA, Ow ZGW, Ho YJ, et al
    Bisphosphonate Therapy after Liver Transplant Improves Bone Mineral Density and Reduces Fracture Rates: An Updated Systematic-Review and Meta-Analysis.
    Transpl Int. 2021 Apr 21. doi: 10.1111/tri.13887.
    PubMed     Abstract available
    
    
    
97. KELLY WU W, Ziogas IA, Izzy M, Pai AK, et al
    Liver transplantation for congenital hepatic fibrosis.
    Transpl Int. 2021 Apr 20. doi: 10.1111/tri.13884.
    PubMed     Abstract available
    
    
    
98. LIM WH, Ng CH, Ow ZGW, Ho OTW, et al
    A Systematic Review and Meta-Analysis on the Incidence of Osteoporosis and Fractures after Liver Transplant.
    Transpl Int. 2021 Apr 9. doi: 10.1111/tri.13863.
    PubMed     Abstract available
    
    
    
99. LEE SA, Hyun J, Yoon YI, Park SY, et al
    Clinical Impact of Mild to Moderate Pulmonary Hypertension in Living-Donor Liver Transplantation.
    Transpl Int. 2021 Apr 2. doi: 10.1111/tri.13875.
    PubMed     Abstract available
    
    
    
100. LECLAIRE JM, Smith NJ, Chandratre S, Rein L, et al
     Solid organ donor-recipient race-matching: analysis of the United Network for Organ Sharing database.
     Transpl Int. 2021;34:640-647.
     PubMed     Abstract available
     
     
     March 2021
101. MOLINARI M, Carrillo CF, Dongling D, Jorgensen D, et al
     Portal Vein Thrombosis and Renal Dysfunction: A National Comparative Study of Liver Transplant Recipients for NAFLD versus Alcoholic Cirrhosis.
     Transpl Int. 2021 Mar 29. doi: 10.1111/tri.13873.
     PubMed     Abstract available
     
     
     
102. OZEN J, Beime J, Brinkert F, Fischer L, et al
     Short- and long-term results of liver transplantation according to age at transplant: a single center experience of 351 children.
     Transpl Int. 2021 Mar 27. doi: 10.1111/tri.13872.
     PubMed     Abstract available
     
     
     
103. CANTU P, Santi G, Rosa R, Parzanese I, et al
     Cost analysis of a long-term randomized controlled study in biliary duct-to-duct anastomotic stricture after liver transplantation.
     Transpl Int. 2021 Mar 17. doi: 10.1111/tri.13867.
     PubMed     Abstract available
     
     
     
104. LOZANOVSKI VJ, Probst P, Arefidoust A, Ramouz A, et al
     Prognostic role of the Donor Risk Index, the Eurotransplant Donor Risk Index and the Balance of Risk score on graft loss after liver transplantation.
     Transpl Int. 2021 Mar 16. doi: 10.1111/tri.13861.
     PubMed     Abstract available
     
     
     
105. YOON YI, Song GW, Lee SG, Park GC, et al
     Safe Use of Right Lobe Living Donor Livers with Moderate Steatosis in Adult-to-adult Living Donor Liver Transplantation: A Retrospective Study.
     Transpl Int. 2021 Mar 4. doi: 10.1111/tri.13859.
     PubMed     Abstract available
     
     
     
106. MAZZOTTA AD, Pascale A, Cano L, Rosmorduc O, et al
     Number Of HCC Nodules in Patients Listed for Liver Transplantation Within Alpha-Fetoprotein Score : a New Prognostic Risk Factor.
     Transpl Int. 2021 Mar 3. doi: 10.1111/tri.13858.
     PubMed     Abstract available
     
     
     February 2021
107. AKAMATSU N, Hasegawa K, Egawa H, Ohdan H, et al
     Donor age (>/= 45 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation - a multicenter retrospective study.
     Transpl Int. 2021 Feb 24. doi: 10.1111/tri.13852.
     PubMed     Abstract available
     
     
     
108. SASAKI K, Nair A, Firl DJ, McVey JC, et al
     Conditional Probability of Graft Survival in Liver Transplantation using Donation after Circulatory Death grafts - a retrospective study.
     Transpl Int. 2021 Feb 17. doi: 10.1111/tri.13846.
     PubMed     Abstract available
     
     
     
109. GAMBATO M, Germani G, Perini B, Gringeri E, et al
     A challenging liver transplantation for decompensated alcoholic liver disease after recovery from SARS-CoV-2 infection.
     Transpl Int. 2021 Feb 8. doi: 10.1111/tri.13842.
     PubMed     Abstract available
     
     
     
110. ABDELAZIZ O, Osman AMA, Hosny KA, Emad-Eldin S, et al
     Management of Early Hepatic Artery Thrombosis following Living-Donor Liver Transplantation: Feasibility, Efficacy and Potential Risks of Endovascular Therapy in the First 48 Hours Post-Transplant.
     Transpl Int. 2021 Feb 4. doi: 10.1111/tri.13839.
     PubMed     Abstract available
     
     
     
111. WANIS KN, Sarvet A, Ruffolo LI, Levstik MA, et al
     Estimating the effect of increasing utilization of living donor liver transplantation using observational data.
     Transpl Int. 2021 Feb 1. doi: 10.1111/tri.13835.
     PubMed     Abstract available
     
     
     January 2021
112. SHALABY S, Taborelli M, Zanetto A, Ferrarese A, et al
     Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation.
     Transpl Int. 2021 Jan 25. doi: 10.1111/tri.13831.
     PubMed     Abstract available
     
     
     
113. CHEN M, Chen Z, Lin X, Hong X, et al
     Application of Ischemia-Free Liver Transplantation Improves Prognosis of Patients with Steatotic Donor Livers.
     Transpl Int. 2021 Jan 23. doi: 10.1111/tri.13828.
     PubMed     Abstract available
     
     
     
114. LOZANOVSKI VJ, Probst P, Ramouz A, Arefidoust A, et al
     Considering Extended Right Lobe grafts as major Extended Donor Criteria in liver transplantation is justified.
     Transpl Int. 2021 Jan 20. doi: 10.1111/tri.13824.
     PubMed     Abstract available
     
     
     
115. RICHARDS JA, Randle LV, Butler MChir AJ, Martin JL, et al
     Pilot study of a non-invasive real-time optical backscatter probe in liver transplantation.
     Transpl Int. 2021 Jan 19. doi: 10.1111/tri.13823.
     PubMed     Abstract available
     
     
     
116. MOURAD M, Lebosse F, Merle P, Levrero M, et al
     External validation of the French AFP model for HCC liver transplantation in a recent unicentric cohort.
     Transpl Int. 2021 Jan 15. doi: 10.1111/tri.13819.
     PubMed     Abstract available
     
     
     
117. FERRARESE A, Sartori G, Orru G, Frigo AC, et al
     Machine Learning in Liver Transplantation: a tool for some unsolved questions?
     Transpl Int. 2021 Jan 11. doi: 10.1111/tri.13818.
     PubMed     Abstract available
     
     
     
118. NAGAI S, Safwan M, Kitajima T, Yeddula S, et al
     Disease-Specific Waitlist Outcomes in Liver Transplantation.
     Transpl Int. 2021 Jan 10. doi: 10.1111/tri.13814.
     PubMed     Abstract available
     
     
     
119. THOMPSON ER, Connelly C, Ali S, Sheerin NS, et al
     Cell therapy during machine perfusion.
     Transpl Int. 2021;34:49-58.
     PubMed     Abstract available
     
     
     
120. PU X, He D, Liao A, Yang J, et al
     A Novel Strategy for Preventing Posttransplant Large-For-Size Syndrome in Adult Liver Transplant Recipients: A Pilot Study.
     Transpl Int. 2022;35:10177.
     PubMed     Abstract available
     
     
     
121. ALEXOPOULOS SP, Wu WK, Ziogas IA, Matsuoka LK, et al
     Adult Combined Heart-Liver Transplantation: The United States Experience.
     Transpl Int. 2022;35:10036.
     PubMed     Abstract available
     
     
     December 2020
122. WOO HY, Hong SK, Cho JH, Lee JM, et al
     Complications of Polytetrafluoroethylene Graft-Use in Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation: A Retrospective, Single-Center, Long-Term, Real-World Experience.
     Transpl Int. 2020 Dec 23. doi: 10.1111/tri.13807.
     PubMed     Abstract available
     
     
     
123. SCHOENBERG MB, Ehmer U, Umgelter A, Bucher JN, et al
     Liver Transplantation versus Watchful-Waiting in Hepatocellular Carcinoma Patients with Complete Response to Bridging-Therapy.
     Transpl Int. 2020 Dec 23. doi: 10.1111/tri.13808.
     PubMed     Abstract available
     
     
     
124. DI SANDRO S, Magistri P, Bagnardi V, Catellani B, et al
     The Covid-19 second wave risk and liver transplantation: lesson from the recent past and the unavoidable need of living donors.
     Transpl Int. 2020 Dec 18. doi: 10.1111/tri.13803.
     PubMed     Abstract available
     
     
     
125. MA L, Li M, Zhang T, Xu JQ, et al
     Incidence of de novo autoimmune hepatitis in children and adolescents with increased autoantibodies after liver transplantation: a meta-analysis.
     Transpl Int. 2020 Dec 14. doi: 10.1111/tri.13801.
     PubMed     Abstract available
     
     
     
126. VAN DEN EYNDE J, Achtergaele J, Fieuws S, Jochmans I, et al
     The effect of organ preservation solutions on short-term outcomes after liver transplantation: a single-centre retrospective study.
     Transpl Int. 2020 Dec 6. doi: 10.1111/tri.13799.
     PubMed     Abstract available
     
     
     
127. POLAK WG, Fondevila C, Karam V, Adam R, et al
     Reply to Rodriguez-Peralvarez et al.
     Transpl Int. 2020;33:1825-1826.
     PubMed    
     
     
     
128. MANGIONI D, Dondossola D, Antonelli B, Alagna L, et al
     Coronavirus disease 2019 and transplantation: tackling the challenges of SARS-CoV-2 infection in waiting list candidates.
     Transpl Int. 2020;33:1830-1832.
     PubMed    
     
     
     November 2020
129. RAUT V, Sonavane A, Shah K, Amruthraj C, et al
     Successful liver transplantation immediately after recovery from COVID-19 in a highly endemic area.
     Transpl Int. 2020 Nov 30. doi: 10.1111/tri.13790.
     PubMed     Abstract available
     
     
     
130. RHU J, Kim JM, Jeong WK, Choi GS, et al
     Venous outflow congestion is related to poor recurrence-free survival of living donor liver transplantation recipients with hepatocellular carcinoma.
     Transpl Int. 2020 Nov 30. doi: 10.1111/tri.13792.
     PubMed     Abstract available
     
     
     
131. NAVEZ J, Iesari S, Kourta D, Baami-Mariza K, et al
     The real incidence of biliary tract complications after adult liver transplantation: the role of the prospective routine use of cholangiography during post-transplant follow-up.
     Transpl Int. 2020 Nov 14. doi: 10.1111/tri.13786.
     PubMed     Abstract available
     
     
     
132. NAM NH, Taura K, Yao S, Kaido T, et al
     Pretransplantation splenomegaly frequently persists after liver transplantation and can manifest as hypersplenism and graft fibrosis - a retrospective study.
     Transpl Int. 2020 Nov 9. doi: 10.1111/tri.13761.
     PubMed     Abstract available
     
     
     
133. VISSEREN T, Fuhler GM, Erler NS, Nossent YRA, et al
     Recurrence of primary sclerosing cholangitis after liver transplantation is associated with specific changes in the gut microbiome pretransplant - a pilot study.
     Transpl Int. 2020;33:1424-1436.
     PubMed     Abstract available
     
     
     October 2020
134. MEMARAN N, Kupper C, Borchert-Morlins B, von Wick A, et al
     Prospective Assessment of Subclinical Cardiovascular Damage and Associated Factors in Liver Transplant Recipients.
     Transpl Int. 2020 Oct 18. doi: 10.1111/tri.13773.
     PubMed     Abstract available
     
     
     
135. IZZY M, Angirekula M, Bentall A, Plevak M, et al
     Role Of Symmetric Dimethylarginine In Predicting Future Renal Impairment In Liver Transplant Recipients.
     Transpl Int. 2020 Oct 17. doi: 10.1111/tri.13771.
     PubMed     Abstract available
     
     
     
136. BRUGGENWIRTH IMA, van Reeven M, Vasiliauskaite I, van der Helm D, et al
     Donor diabetes mellitus is a risk factor for diminished outcome after liver transplantation: a nationwide retrospective cohort study.
     Transpl Int. 2020 Oct 17. doi: 10.1111/tri.13770.
     PubMed     Abstract available
     
     
     
137. PINERO F, Anders M, Boin IF, Chagas A, et al
     Liver transplantation for hepatocellular carcinoma: impact of expansion criteria in a multicenter cohort study from a high waitlist mortality region."
     Transpl Int. 2020 Oct 11. doi: 10.1111/tri.13767.
     PubMed     Abstract available
     
     
     
138. DE CARLIS R, Buscemi V, Checchini G, Frassoni S, et al
     Liver transplantation from brain-dead donors on mechanical circulatory support: a systematic review of the literature.
     Transpl Int. 2020 Oct 9. doi: 10.1111/tri.13766.
     PubMed     Abstract available
     
     
     
139. MELANDRO F, Ghinolfi D, Balzano E, Tincani G, et al
     Light at the end of the tunnel: COVID-19 lockdown has not halted liver transplantation at a high volume center in Italy.
     Transpl Int. 2020 Oct 8. doi: 10.1111/tri.13764.
     PubMed     Abstract available
     
     
     
140. KOVANDOVA B, Slavcev A, Honsova E, Erhartova D, et al
     De Novo HLA Class II Antibodies Are Associated with the Development of Chronic but not Acute Antibody-Mediated Rejection after Liver Transplantation.
     Transpl Int. 2020 Oct 5. doi: 10.1111/tri.13763.
     PubMed     Abstract available
     
     
     
141. BOFFINI M, Pidello S, Simonato E, Barbero C, et al
     An effective protocol for heart transplantation during COVID-19 outbreak.
     Transpl Int. 2020;33:1326-1328.
     PubMed    
     
     
     September 2020
142. CHOI D, Liu M, Guttikonda D, Galen K, et al
     Recipient Risk Factors for Acute Cellular Rejection After Orthotopic Liver Transplant.
     Transpl Int. 2020 Sep 29. doi: 10.1111/tri.13756.
     PubMed     Abstract available
     
     
     
143. PASCALE MM, Bianco G, Ferri L, Agnes S, et al
     COVID-19 health restrictions in a transplanted Italian cohort.
     Transpl Int. 2020;33:1151-1153.
     PubMed    
     
     
     
144. SHI H, Xu J, Li X, Zhao Y, et al
     First organ donation in Wuhan after ending of the coronavirus lockdown.
     Transpl Int. 2020;33:1149-1150.
     PubMed    
     
     
     October 2019
145. YAZAWA M, Cseprekal O, Helmick RA, Talwar M, et al
     Association Between Post-Transplant Donor Specific Antibodies and Recipient Outcomes in Simultaneous Liver-Kidney Transplant Recipients: single center, cohort study.
     Transpl Int. 2019 Oct 24. doi: 10.1111/tri.13543.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Transplantation is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: